Mixed-ligand strategy affording two new metal-organic frameworks: Photocatalytic, luminescent and anti-lung cancer properties

Metal-organic frameworks as a therapeutic strategy for lung diseases

Lung diseases remain a global burden today. Lower respiratory tract infections alone cause more than 3 million deaths worldwide each year and are on the rise every year. In particular, with coronavirus disease raging worldwide since 2019, we urgently require a treatment for lung disease. Metal organic frameworks (MOFs) have a broad application prospect in the biomedical field due to their remarkable properties. The unique properties of MOFs allow them to be applied as delivery materials for different drugs; diversified structural design endows MOFs with diverse functions; and they can be designed as various MOF-drug synergistic systems. This review concentrates on the synthesis design and applications of MOF based drugs against lung diseases, and discusses the possibility of preparing MOF-based inhalable formulations. Finally, we discuss the chances and challenges of using MOFs for targeting lung diseases in clinical practice.

Recent advances in MOF-based photocatalysis: environmental remediation under visible light

Highly photoactive MOFs can be engineered via various strategies for the purpose of extended visible light absorption, more efficient generation, separation and transfer of charge carriers, as well as good recyclability.